SE8004253L - Nya 4-aroylimidazol-2-oner - Google Patents

Nya 4-aroylimidazol-2-oner

Info

Publication number
SE8004253L
SE8004253L SE8004253A SE8004253A SE8004253L SE 8004253 L SE8004253 L SE 8004253L SE 8004253 A SE8004253 A SE 8004253A SE 8004253 A SE8004253 A SE 8004253A SE 8004253 L SE8004253 L SE 8004253L
Authority
SE
Sweden
Prior art keywords
alkyl
phenyl
hydrogen
alkoxy
hydroxy
Prior art date
Application number
SE8004253A
Other languages
English (en)
Other versions
SE447107B (sv
Inventor
R A Schnettler
R C Dage
J M Grisar
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26727558&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8004253(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of SE8004253L publication Critical patent/SE8004253L/sv
Publication of SE447107B publication Critical patent/SE447107B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE8004253A 1979-06-18 1980-06-06 Nya 4-aroylimidazol-2-oner SE447107B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4980879A 1979-06-18 1979-06-18
US11920780A 1980-02-07 1980-02-07

Publications (2)

Publication Number Publication Date
SE8004253L true SE8004253L (sv) 1980-12-19
SE447107B SE447107B (sv) 1986-10-27

Family

ID=26727558

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8004253A SE447107B (sv) 1979-06-18 1980-06-06 Nya 4-aroylimidazol-2-oner
SE8501452A SE464559B (sv) 1979-06-18 1985-03-25 Farmaceutisk komposition innehaallande 4-aroylimidazol-2-oner med antihypertensiv, kardioton och antitrombotisk verkan

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8501452A SE464559B (sv) 1979-06-18 1985-03-25 Farmaceutisk komposition innehaallande 4-aroylimidazol-2-oner med antihypertensiv, kardioton och antitrombotisk verkan

Country Status (20)

Country Link
AT (1) AT375349B (sv)
AU (1) AU532783B2 (sv)
CA (1) CA1132554A (sv)
CH (1) CH646155A5 (sv)
DE (1) DE3021792A1 (sv)
DK (1) DK160269C (sv)
ES (1) ES8105299A1 (sv)
FR (1) FR2459233A1 (sv)
GB (1) GB2055364B (sv)
HK (1) HK61486A (sv)
HU (1) HU186736B (sv)
IE (1) IE50646B1 (sv)
IL (1) IL60243A (sv)
IT (1) IT1143922B (sv)
MY (1) MY8600709A (sv)
NL (2) NL193752C (sv)
NO (1) NO152841C (sv)
NZ (1) NZ193935A (sv)
PH (1) PH18683A (sv)
SE (2) SE447107B (sv)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones
US4405628A (en) * 1981-03-05 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Pyridylimidazolones and method of use
US4329471A (en) * 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 4-(4-Phenyl-1-piperidinyl)methyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones
US4371737A (en) * 1981-05-04 1983-02-01 Merrell Dow Pharmaceuticals Inc. 5-Aminomethyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
AU549872B2 (en) * 1981-05-04 1986-02-20 Merrell Dow Pharmaceuticals Inc. 4-oxymethyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones
US4381393A (en) * 1981-05-04 1983-04-26 Merrell Dow Pharmaceuticals Inc. 4-Aminomethyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones
US4526981A (en) * 1981-05-04 1985-07-02 Merrell Dow Pharmaceuticals Inc. [1,2-Dihydro-4(5)-acyl-2-oxo-2H-imidazol-4(5)-yl] methyl nitrates
US4329470A (en) * 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 5-(4-Phenyl 1-piperidinyl)methyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
US4410540A (en) * 1981-11-04 1983-10-18 Merrell Dow Pharmaceuticals Inc. Cardiotonic 4-aroylimidazolidin-2-ones
US4367236A (en) 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
WO2005092332A1 (en) * 2004-03-22 2005-10-06 Myogen, Inc. (s) - enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
US20060030611A1 (en) * 2004-03-22 2006-02-09 Myogen, Inc. Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases
AU2006311577B2 (en) 2005-11-09 2013-02-07 Zalicus Inc. Methods, compositions, and kits for the treatment of medical conditions
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EA201391254A1 (ru) 2011-03-01 2014-02-28 Синерджи Фармасьютикалз Инк. Способ получения агонистов гуанилатциклазы c
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
JP6499591B2 (ja) 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
CN105764916B (zh) 2013-06-05 2021-05-18 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
EP3492106B1 (en) 2013-08-09 2021-02-17 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
EP3972599B1 (en) 2019-05-21 2025-10-22 Ardelyx, Inc. Combination for lowering serum phosphate in a patient
CN114539157B (zh) * 2022-03-03 2023-12-22 曲靖师范学院 一种碘促进氧化法制备4-碘代n-芳基吡唑类化合物的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them

Also Published As

Publication number Publication date
IE801162L (en) 1980-12-18
ATA314280A (de) 1983-12-15
NL300015I2 (nl) 2000-10-02
NL300015I1 (nl) 2000-11-01
SE464559B (sv) 1991-05-13
PH18683A (en) 1985-08-29
IL60243A0 (en) 1980-09-16
ES492255A0 (es) 1981-06-01
DK160269C (da) 1991-07-22
DK259080A (da) 1980-12-19
GB2055364A (en) 1981-03-04
MY8600709A (en) 1986-12-31
DK160269B (da) 1991-02-18
AT375349B (de) 1984-07-25
NO152841C (no) 1985-11-27
HK61486A (en) 1986-08-29
DE3021792A1 (de) 1981-01-22
GB2055364B (en) 1983-06-08
AU5911880A (en) 1981-01-08
NO152841B (no) 1985-08-19
CH646155A5 (de) 1984-11-15
NO801796L (no) 1980-12-19
IL60243A (en) 1987-01-30
FR2459233B1 (sv) 1983-09-23
NZ193935A (en) 1985-05-31
FR2459233A1 (fr) 1981-01-09
AU532783B2 (en) 1983-10-13
HU186736B (en) 1985-09-30
SE8501452D0 (sv) 1985-03-25
IE50646B1 (en) 1986-06-11
ES8105299A1 (es) 1981-06-01
DE3021792C2 (sv) 1989-08-10
NL8003498A (nl) 1980-12-22
CA1132554A (en) 1982-09-28
IT8048997A0 (it) 1980-06-17
IT1143922B (it) 1986-10-29
NL193752B (nl) 2000-05-01
SE8501452L (sv) 1985-03-25
NL193752C (nl) 2000-09-04
SE447107B (sv) 1986-10-27

Similar Documents

Publication Publication Date Title
SE8004253L (sv) Nya 4-aroylimidazol-2-oner
DK623586D0 (da) Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne
FI915970A0 (fi) Laekemedel, som aer nyttiga vid vaord av cancer och som har antihistaminegenskaper.
EP0632031A4 (sv)
FI860111A0 (fi) Terapeutiska medel.
SE8403801D0 (sv) Nya bensotiazepiner med kardiovaskuler anvendbarhet, forfarande for framstellning derav och farmaceutiska kompositioner som innehaller dem
PT69618A (de) Neue imidazolderivate verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praparate
DE69311118D1 (de) Phosphono-arylethanolamin-verbindungen mit antihyperglykämischer und/oder antiobeser wirkung
NO890440L (no) Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater.
DK37580A (da) 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater samt deres fremstilling og anvendelse
SE7704536L (sv) Forfarande for framstellning av fenylpiperazinderivat
MX4767E (es) Procedimiento para la preparacion de derivados del 1,8-etano-5-oxo octa y decahidroquinolinas
ES509636A0 (es) "procedimiento para preparar nuevos compuestos de aroilimidazol-2-onas".
YU6996A (sh) Upotreba benzotiofena za dobijanje leka
ES517042A0 (es) Procedimiento para la preparacion de una aroilimidazolidin-2-ona.
FI810426L (fi) Foerfarande foer framstaellning av nya triazokinazolinon-derivat
SE8406046D0 (sv) New azabiocyclic compounds and a process for the preparation thereof
FI862570A0 (fi) Nya aromatiska foereningar, deras ramstaellning och anvaendning.
FI811527L (fi) Nya imidazolderivat
SE7606497L (sv) Substituerade 4-fenylimidazoliner, deras syraadditinossalter och forfarande for framstellning derav
FI823732L (fi) Nya 1-furyl-3,4-dihydroisokinoliner, laekemedel innehaollande dessa samt deras framstaellningsfoerfaranden och deras anvaendning
FI803970L (fi) Nya substituerade 4-amino-2,6-diaryl-tetrahydrotiopyraner deras syraadditionssalter deras framstaellningsfoerfarande deras anvaendning och farmaceutiska blandningar
ES454285A1 (es) Procedimiento para preparar derivados de 4-amina trans-deca-hidroquinolina.
SE8701524L (sv) Nya sulfonamider och deras framstaellningsfoerfarande
IL66692A0 (en) 6alpha-methoxy-penicillins and salts thereof,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8004253-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8004253-4

Format of ref document f/p: F